ArticlePloS one2025
Comparative metabolic study of planktonic and sessile cells in Salmonella Enteritidis ATCC 13076: Elucidating metabolic pathways driving biofilm formation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Comparative Biofilmomics of Antimicrobial-ResistantAnimals : an open access journal from MDPI · 2026Review
- In Vitro Antifungal Activity of Essential Oils and Nanoemulsions ofAntibiotics (Basel, Switzerland) · 2026Article
- Efficacy of peracetic acid and chlorine in managingApplied and environmental microbiology · 2026Article
- Bacillus cereus-derived α-amylase disrupts biofilm formation and quorum sensing in multidrug-resistant Klebsiella pneumoniae.BMC microbiology · 2025Article
- Decoding the regulatory networks ofFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microorganisms tend to accumulate on surfaces, forming aggregates such as biofilms, which grant them resistance to various environmental stressors and antimicrobial agents. This ability has hindered the effective treatment of diseases caused by pathogenic microorganisms, including Salmonella, which is responsible for a significant number of deaths worldwide. This study aimed to compare the metabolic profiles of planktonic and sessile cells of Salmonella Enteritidis using a metabolomics approach. The metabolites extracted from the bacterial cells were analyzed by LC/MS approach. Raw data were analyzed using Thermo Xcalibur v 3.1 software. For data processing, XCMS was used for feature detection, retention time, correction and alignment. The data matrix was analyzed by uni- and multivariate statistical methods (PCA, PLS-DA, Heatmap) in MetaboAnalyst software v 6.0. A total of 121 metabolites were presumptively identified as differential metabolic characteristics between the two bacterial states, and they were associated with their corresponding metabolic pathways. Among the metabolites that exhibited positive modulation in planktonic cells were proline, phenylalanine, which act as precursors of essential metabolites and part of the stress adaptation mechanisms. In addition, putrescine and cadaverine, play crucial roles in growth, stress response, and cell stability In contrast, the most representative metabolites in sessile cells included lysine, adenosine, purines, pyrimidines, and citrate, mainly associated with maintaining cellular homeostasis, stress response and metabolic regulation. Finally, pathway enrichment analysis identified metabolic changes in 11 pathways, predominantly involving purine and pyrimidine metabolism, arginine and proline metabolism, and vitamin B6 metabolism. These findings facilitated the identification of potential metabolic pathways associated with biofilm formation in the sessile cells of Salmonella Enteritidis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.